Miles Jervis-Denison

Novartis ‘Get Smart' Meeting Series - knowledge and skills for MS specialist nurses

Novartis identified an opportunity to assist the nursing community with the education and investment required to cement and celebrate the role of MS specialist nurses in the UK. To meet this need, we worked with an MS nurse steering committee to create the ‘Get Smart’ education programme. This brought key specialists together to create a meeting series that aimed to build the profile of the MS specialist… Show more

Novartis ‘Get Smart' Meeting Series - knowledge and skills for MS specialist nurses

Novartis identified an opportunity to assist the nursing community with the education and investment required to cement and celebrate the role of MS specialist nurses in the UK. To meet this need, we worked with an MS nurse steering committee to create the ‘Get Smart’ education programme. This brought key specialists together to create a meeting series that aimed to build the profile of the MS specialist nurse in the UK. Through creative execution and practical skills
training, the ‘Get Smart’ programme has exceeded expectations and has resulted in a real movement to protect and enhance the profile of the specialists who strive to improve the lives of people affected by MS

http://www.pmlive.com/awards/communique/communique_awards_2016_results/healthcare_communications_awards/excellence_in_communications_via_meetings/get_smart_meeting_series_-_knowledge_and_skills_for_ms_specialist_nurses Show less

In our sixth year, we found ourselves under new management and embarking upon a pioneering next phase. Concentrating on the core essentials, we ensured our processes were robust and our scientific quality second to none, while expanding our service offering to encompass innovative methods for better understanding and engaging healthcare professionals (HCPs).

Our excellence relied on a strong healthcare curiosity. With a heritage built on a medical learning approach to facilitate… Show more

In our sixth year, we found ourselves under new management and embarking upon a pioneering next phase. Concentrating on the core essentials, we ensured our processes were robust and our scientific quality second to none, while expanding our service offering to encompass innovative methods for better understanding and engaging healthcare professionals (HCPs).

Our excellence relied on a strong healthcare curiosity. With a heritage built on a medical learning approach to facilitate behaviour change, next it was time to focus on understanding what needs to change. We encouraged each team member to have a 360º experience of healthcare in action. We learnt from HCPs and patients and evolved the way we design our programmes to focus on what’s important to them, delivering the impactful behavioural change that we promised.

Testament to the success of this approach was that half of our new business income was from organic growth. We exceeded our financial target with a 9% growth rate, making up half of Virgo’s total revenue. We achieved growth by retaining 100% of clients and substantially growing the existing account base.

It was evolution not revolution, and it made a difference. We believe the results speak for themselves.

http://www.pmlive.com/awards/communique/communique_awards_2016_results/individual,_team_and_company_awards/the_lucid_award_for_medical_education_consultancy_of_the_year Show less

Developed a suite of cutting-edge training portals to facilitate investigator training for a number of Roche's key clinical trials. This was the second award for this project.

http://www.pmlive.com/awards/pmea/pmea_awards_2015_results/company_awards/excellence_in_training_capability_development

Made it to the final four of the Young Achiever in Healthcare Communications category.

http://www.pmlive.com/awards/communique/communique_awards_2015_results/individual,_team_and_company_awards/the_hamell_award_for_young_achiever_in_healthcare_communications/miles_denison

Developed a suite of cutting-edge training portals to facilitate investigator training for a number of Roche's key clinical trials.

http://pmsociety.org.uk/awards/digital/2014/results/digital-tools-for-use-in-a-practical-setting-judged-by-hcps-in-pharma